Literature DB >> 16542009

Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models.

Artem S Novozhilov1, Faina S Berezovskaya, Eugene V Koonin, Georgy P Karev.   

Abstract

BACKGROUND: Oncolytic viruses that specifically target tumor cells are promising anti-cancer therapeutic agents. The interaction between an oncolytic virus and tumor cells is amenable to mathematical modeling using adaptations of techniques employed previously for modeling other types of virus-cell interaction.
RESULTS: A complete parametric analysis of dynamic regimes of a conceptual model of anti-tumor virus therapy is presented. The role and limitations of mass-action kinetics are discussed. A functional response, which is a function of the ratio of uninfected to infected tumor cells, is proposed to describe the spread of the virus infection in the tumor. One of the main mathematical features of ratio-dependent models is that the origin is a complicated equilibrium point whose characteristics determine the main properties of the model. It is shown that, in a certain area of parameter values, the trajectories of the model form a family of homoclinics to the origin (so-called elliptic sector). Biologically, this means that both infected and uninfected tumor cells can be eliminated with time, and complete recovery is possible as a result of the virus therapy within the framework of deterministic models.
CONCLUSION: Our model, in contrast to the previously published models of oncolytic virus-tumor interaction, exhibits all possible outcomes of oncolytic virus infection, i.e., no effect on the tumor, stabilization or reduction of the tumor load, and complete elimination of the tumor. The parameter values that result in tumor elimination, which is, obviously, the desired outcome, are compatible with some of the available experimental data. REVIEWERS: This article was reviewed by Mikhail Blagosklonny, David Krakauer, Erik Van Nimwegen, and Ned Wingreen. OPEN PEER REVIEW: Reviewed by Mikhail Blagosklonny, David Krakauer, Erik Van Nimwegen, and Ned Wingreen. For the full reviews, please go to the Reviewers' comments section.

Entities:  

Year:  2006        PMID: 16542009      PMCID: PMC1403749          DOI: 10.1186/1745-6150-1-6

Source DB:  PubMed          Journal:  Biol Direct        ISSN: 1745-6150            Impact factor:   4.540


  37 in total

1.  How should pathogen transmission be modelled?

Authors:  H McCallum; N Barlow; J Hone
Journal:  Trends Ecol Evol       Date:  2001-06-01       Impact factor: 17.712

2.  Universal law of tumor growth.

Authors:  Michael Retsky
Journal:  J Theor Biol       Date:  2004-08-07       Impact factor: 2.691

3.  Viruses as antitumor weapons: defining conditions for tumor remission.

Authors:  D Wodarz
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

4.  Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer.

Authors:  J Nemunaitis; F Khuri; I Ganly; J Arseneau; M Posner; E Vokes; J Kuhn; T McCarty; S Landers; A Blackburn; L Romel; B Randlev; S Kaye; D Kirn
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

5.  The competitive dynamics between tumor cells, a replication-competent virus and an immune response.

Authors:  Youshan Tao; Qian Guo
Journal:  J Math Biol       Date:  2005-03-15       Impact factor: 2.259

6.  Population dynamics of immune responses to persistent viruses.

Authors:  M A Nowak; C R Bangham
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

Review 7.  Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies.

Authors:  Robert A Gatenby; Thomas L Vincent
Journal:  Mol Cancer Ther       Date:  2003-09       Impact factor: 6.261

8.  An evolutionary model of carcinogenesis.

Authors:  Robert A Gatenby; Thomas L Vincent
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

Review 9.  Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.

Authors:  Amish C Shah; Dale Benos; G Yancey Gillespie; James M Markert
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.506

Review 10.  Intravascular adenoviral agents in cancer patients: lessons from clinical trials.

Authors:  Tony Reid; Robert Warren; David Kirn
Journal:  Cancer Gene Ther       Date:  2002-12       Impact factor: 5.987

View more
  21 in total

Review 1.  Viruses as anticancer drugs.

Authors:  Stephen J Russell; Kah-Whye Peng
Journal:  Trends Pharmacol Sci       Date:  2007-06-18       Impact factor: 14.819

2.  Use of oncolytic viruses for the eradication of drug-resistant cancer cells.

Authors:  Dominik Wodarz
Journal:  J R Soc Interface       Date:  2009-02-06       Impact factor: 4.118

3.  Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer.

Authors:  Erin S Haley; Gough G Au; Brian R Carlton; Richard D Barry; Darren R Shafren
Journal:  J Mol Med (Berl)       Date:  2009-01-13       Impact factor: 4.599

4.  Richards-like two species population dynamics model.

Authors:  Fabiano Ribeiro; Brenno Caetano Troca Cabella; Alexandre Souto Martinez
Journal:  Theory Biosci       Date:  2014-08-13       Impact factor: 1.919

5.  Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling.

Authors:  D M Rommelfanger; C P Offord; J Dev; Z Bajzer; R G Vile; D Dingli
Journal:  Gene Ther       Date:  2011-09-15       Impact factor: 5.250

6.  On the laws of virus spread through cell populations.

Authors:  Dominik Wodarz; Chi N Chan; Benjamin Trinité; Natalia L Komarova; David N Levy
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

7.  ODE models for oncolytic virus dynamics.

Authors:  Natalia L Komarova; Dominik Wodarz
Journal:  J Theor Biol       Date:  2010-01-18       Impact factor: 2.691

Review 8.  Computational modeling approaches to the dynamics of oncolytic viruses.

Authors:  Dominik Wodarz
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-03-22

9.  Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection.

Authors:  Dominik Wodarz; Natalia Komarova
Journal:  PLoS One       Date:  2009-01-30       Impact factor: 3.240

10.  Modeling protective anti-tumor immunity via preventative cancer vaccines using a hybrid agent-based and delay differential equation approach.

Authors:  Peter S Kim; Peter P Lee
Journal:  PLoS Comput Biol       Date:  2012-10-25       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.